TRACKER 6 OCT 2026 · WADA publishes the 2027 Prohibited List, in force January 1, 2027. What changed

Peptides A-Z

We collect and compare information from public, cited sources. We cannot guarantee that it is complete, current or correct. This is not medical advice. Only a doctor can prescribe, and a doctor should confirm anything you read here before you act on it.

Based on public sources; we cannot guarantee it is correct. Not medical advice. A doctor should prescribe and confirm. Full disclaimer

BPC-157 Synthetic 15-amino-acid fragment of a gastric protein
Evidence grade C
FDA: not approved503A compounding: under reviewWADA S0 · prohibited at all times
Epitalon Synthetic tetrapeptide marketed for longevity
Not yet graded
FDA: not approved503A compounding: under reviewWADA: not named, ask USADA
GHK-Cu Copper-binding three-amino-acid peptide found in human blood
Evidence grade C
Not approved as a drug503A compounding: not eligibleWADA: not named, ask USADA
KPV Three-amino-acid fragment of the hormone alpha-MSH
Evidence grade D
FDA: not approved503A compounding: under reviewWADA: not named, ask USADA
MOTS-c Mitochondria-derived peptide studied for metabolism
Not yet graded
FDA: not approved503A compounding: under reviewWADA: not named, ask USADA
PT-141 Melanocortin peptide approved for low sexual desire in some women
Approved
FDA approved, one useWADA: being checked
Retatrutide Triple-agonist weight-loss drug in late-stage trials
Evidence grade A
FDA: investigationalWADA: not named, ask USADA
Semax Synthetic peptide approved as a medicine in Russia, not the US
Not yet graded
FDA: not approved503A compounding: under reviewWADA: not named, ask USADA
Sermorelin Former FDA drug; growth-hormone-releasing hormone fragment
Not yet graded
FDA: formerly approvedCompounding: being checkedWADA S2 · prohibited at all times
SS-31 Mitochondria-targeted peptide approved narrowly for Barth syndrome
Approved
FDA approved, one useWADA: not named, ask USADA
TB-500 Synthetic fragment of thymosin beta-4, a repair-related protein
Evidence grade D
FDA: not approved503A compounding: under reviewWADA S2 · prohibited at all times
Tesamorelin Growth-hormone-releasing peptide approved for one use
Approved
FDA approved, one useWADA S2 · prohibited at all times
Tirzepatide FDA-approved GIP and GLP-1 drug for type 2 diabetes and weight
Approved
FDA approvedWADA: not prohibited